Artemisinin/Hydroxychloroquine sulfate

青蒿素/硫酸羟氯喹

Report date: 2022/03/29 13:53:21

Base Information

Drug NameArtemisinin/Hydroxychloroquine sulfate
Drug Alias Name青蒿素硫酸羟氯喹片
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADH-ubiquinone oxidoreductase chain 4 modulators
TargetsNADH-ubiquinone oxidoreductase chain 4
Therapy Area/IndicationsMalaria, Falciparum
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes ArtemisininHydroxychloroquine sulfate
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Chinese Medicine University Technology Industry Park Co LtdArtepharm Co Ltd China
Inactive CompaniesN/A
Active IndicationsMalaria, Falciparum
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A